Drugs & Targets FDA approval makes Tecentriq the first adjuvant treatment for NSCLC October 15, 2021Vol.47 No.38
Drugs & Targets Verzenio with endocrine therapy gets FDA approval for early breast cancer October 15, 2021Vol.47 No.38
Drugs & Targets Keytruda combination gets FDA approval for first-line cervical cancer treatment October 15, 2021Vol.47 No.38
Drugs & Targets FDA authorizes first e-cigarette products, alarming cancer prevention advocates October 15, 2021Vol.47 No.38
Drugs & Targets Qinlock approved in Switzerland for fourth-line gastrointestinal stromal tumor October 15, 2021Vol.47 No.38
Drugs & Targets Mayo Clinic collaborates with Personalis to expand cancer genomic testing October 15, 2021Vol.47 No.38
Drugs & Targets Pillar Biosciences, Labcorp collaborate on next-generation sequencing October 15, 2021Vol.47 No.38
In Brief Stanford neuro-oncologist Michelle Monje named MacArthur Fellow October 01, 2021Vol.47 No.36
